Sai Life Sciences
PublicSai Life Sciences is now publicly traded
The data on this page reflects Sai Life Sciences's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Dec 18, 2024
Last Round
Private Equity
Jul 25, 2018
Est. Valuation at Exit
$311M
Total Funding Raised
$131.76M
Company Overview
Sai (Pharmaceuticals) is a healthcare services company that accelerates the discovery, development, and commercialization of new chemical entity small molecule programs through fully equipped facilities designed for quality and responsiveness, helping biotech and pharma clients achieve rapid development milestones and market launches.
Sector
Biotech
AI Layer
Non-AI
Keywords
Sai Life Sciences Comparables
Compare Sai Life Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioDuro-Sundia | 84% | |
| Bellen Chemistry | 83% | |
| Concept Life Sciences | 70% |
Sai Life Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Dec 18, 2024 | ||||
| Private Equity | Jul 25, 2018 | ||||
| VC Round | May 14, 2008 | ||||
| Secondary | Oct 27, 2007 |
Sai Life Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MPM Capital | VC Round |
| Axis Asset Management Company | IPO |
| Ashoka WhiteOak Capital | IPO |
| Peak XV Partners | Secondary |
| Kotak Mahindra Mutual Fund | IPO |
| Morgan Stanley | IPO |
| Aditya Birla Sun Life AMC | IPO |
Sai Life Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access